The US antifoaming agent market is witnessing stable growth amid expanding industrial applications, robust research and development, and increasing demand from end-use sectors such as food & beverages, pharmaceuticals, and wastewater treatment. Growing regulatory standards and focus on process optimization further drive market developments.
The economic impact of tariffs on "US Antifoaming Agent Market".
Market Growth Drivers
Rising Demand from Food & Beverage Industry: Increasing consumption of processed food and beverages in the US has necessitated the widespread use of antifoaming agents for enhanced product quality and manufacturing efficiency. Companies such as BASF SE have expanded their product portfolios with food-grade antifoaming agents that help reduce foam in dairy processing and beverage bottling lines, ensuring consistency and compliance with safety standards.
Expansion of Wastewater Treatment Activities: With stringent regulations set by the Environmental Protection Agency (EPA), the adoption of antifoaming agents in municipal and industrial wastewater treatment facilities is on the rise. For instance, Evonik Industries AG has introduced water-based silicone defoamers designed for high-efficiency foam control, enabling environment-friendly operations and reducing maintenance costs for water treatment companies.
Market Trends
Increasing Preference for Silicone-Based Antifoaming Agents: The US market is seeing a significant shift towards silicone-based antifoaming agents due to their superior performance and stability across diverse industrial applications. For example, Dow Inc. has introduced advanced silicone defoamer solutions tailored for pulp & paper and paints & coatings, supporting enhanced operational efficiency and environmental compliance.
Adoption of Bio-Based Defoamers: Sustainability is driving innovation, with manufacturers such as Ashland Global Holdings Inc. focusing on bio-based and biodegradable antifoaming agents. These products target customers in food processing and pharmaceutical segments seeking environmentally friendly alternatives, reflecting the increasing regulatory and consumer preferences for green chemistry solutions.
Market Opportunities
Growth in Pharmaceutical Manufacturing: The expanding US pharmaceutical sector presents lucrative opportunities for antifoaming agent suppliers. Companies like Momentive Performance Materials are targeting this vertical with specialized, high-purity antifoaming agents to support efficient drug formulation and production.
Technological Advancements in Agricultural Chemicals: The development of crop protection chemicals featuring integrated antifoaming technologies is emerging as a major opportunity. FMC Corporation is investing in R&D for novel defoamer additives to improve application efficiency and minimize environmental impact in agrochemical sprays.
US Antifoaming Agent Market Revenue (USD Million), 2020-2035
The US antifoaming agent market revenue is projected to increase steadily from 2020 through 2035. Beginning at USD 815 million in 2020, the market is expected to grow to USD 880 million in 2022 and USD 980 million in 2025. With expanding applications in key end-use industries and ongoing R&D in bio-based and silicone solutions, the market is forecasted to reach approximately USD 1,450 million by 2035. The chart depicts a clear upward trend, indicating stable year-on-year growth driven by industrial modernization and regulatory compliance requirements.
US Antifoaming Agent Market Share by Region (%), 2025
In 2025, the antifoaming agent market in the US is notably led by the Midwest region, which accounts for the largest share due to its dense concentration of food processing and manufacturing industries. The West and South also command substantial market shares, benefitting from growth in pharmaceuticals and agrochemicals. The Northeast and Central regions collectively represent a notable share, driven by investments in industrial water treatment facilities. The pie chart highlights this regional distribution, reflecting patterns of industrial activity and market penetration.
Recent Developments in the US Antifoaming Agent Market
In April 2024, Dow Inc. announced the launch of their new silicone-based antifoaming agent line, DOWSIL™ AFM 5020, targeting the paper and pulp as well as paint & coatings sectors. This addition aims to provide enhanced foam control, lower toxicity, and greater compatibility with water-based systems, underlining Dow’s commitment to sustainable industrial solutions.
BASF SE, in March 2024, revealed an investment initiative to increase capacity at its Pasadena, Texas, facility dedicated to the production of food-grade antifoaming agents. This expansion reinforces BASF’s role in meeting the growing demand for safe food additives in North America, and ensuring scalable supply with a focus on regulatory compliance.
Evonik Industries, in May 2024, introduced a new series of bio-based antifoaming agents for wastewater treatment plants across the US. Developed through proprietary fermentation processes, these defoamers offer rapid foam suppression, improved biodegradability, and minimized chemical footprint—catering to municipalities and industrial operators aiming for greener water management practices.
Press Releases